Novus Therapeutics, Inc. | Business Contracts

License Agreement between Lonza Sales AG and Anelixis Therapeutics, LLC, dated September 11, 2018 (Filed With SEC on August 11, 2022)

SUBLEASE AGREEMENT BY AND BETWEEN CORPORATE TECHNOLOGIES, INC., SUBLANDLORD AND ELEDON PHARMACEUTICALS, INC., SUBTENANT A PORTION OF 78 Blanchard Road, Burlington, MA 01803... (Filed With SEC on March 24, 2022)

ELEDON PHARMACEUTICALS, INC. Stock Option Agreement Granted Under 2020 Long Term Incentive Plan (Filed With SEC on March 24, 2022)

Series X1 Exchange Agreement, dated January 11, 2022, by and among Eledon Pharmaceuticals, Inc. and the Stockholders named therein (Filed With SEC on January 13, 2022)

Description of Securities (Filed With SEC on March 31, 2021)

Open Market Sales Agreement by and between the Registrant and Jefferies, LLC dated March 30, 2021 (Filed With SEC on March 31, 2021)

First Amendment to Restated License Agreement between ALS Therapy Development Foundation, Inc. and Anelixis Therapeutics, Inc. dated September 5, 2020 (Filed With SEC on August 11, 2022)

Amended and Restated License Agreement by and between ALS Therapy Development Foundation, Inc. and Anelixis Therapeutics, Inc, dated February 18, 2020 (Filed With SEC on August 11, 2022)

SECOND AMENDMENT TO LEASE (Filed With SEC on March 24, 2022)

Executive Employment Agreement, dated September 9, 2020, between Novus Therapeutics, Inc. and David-Alexandre C. Gros, M.D (Filed With SEC on March 31, 2021)

Novus Therapeutics, Inc., 2020 Long Term Incentive Plan (Filed With SEC on March 31, 2021)

Executive Employment Agreement, dated March 15, 2021, between Eledon Pharmaceuticals, Inc. and Paul Little (Filed With SEC on March 31, 2021)

Executive Employment Agreement, dated March 1, 2021, between Eledon Pharmaceuticals, Inc. and Jon Kuwahara (Filed With SEC on March 31, 2021)

Warrant Exchange Agreement, dated December 31, 2020, by and among Novus Therapeutics, Inc. and the Stockholders named therein (Filed With SEC on January 7, 2021)

Series X Exchange Agreement, dated December 31, 2020, by and among Novus Therapeutics, Inc. and the Stockholders named therein (Filed With SEC on January 7, 2021)

Description of Securities (Filed With SEC on March 17, 2020)

Exchange Agreement, dated February 13, 2020, by and among Novus Therapeutics, Inc. and the Stockholders named therein (Filed With SEC on February 19, 2020)

Form of Warrant Exercise Agreement by and between Novus Therapeutics, Inc. and the Holders named therein (Filed With SEC on January 16, 2020)

Form of Private Placement Warrant (Filed With SEC on January 16, 2020)

Management Continuity Agreement, date August 7, 2017, between Novus Therapeutics, Inc. and Catherine C. Turkel (Filed With SEC on May 14, 2019)

Form of Securities Purchase Agreement, dated April 30, 2019, by and between Novus Therapeutics, Inc. and the Purchasers named therein (Filed With SEC on May 2, 2019)

Form of Placement Agent Warrant (Filed With SEC on May 2, 2019)

Form of Warrant (Filed With SEC on May 2, 2019)

Executive Employment Agreement, dated November 10, 2015, between Otic Pharma, Inc. and Catherine C. Turkel (Filed With SEC on March 28, 2019)

Novus Therapeutics, Inc. (24)